Novo Nordisk Aktie
58,80
EUR
+0,35
EUR
+0,60
%
59,37
EUR
+0,05
EUR
+0,08
%
Werbung
Novo Nordisk Aktie Analyse
| 09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
| 09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
| 26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
| 03.05.16 | Novo Nordisk Halten | Independent Research GmbH | |
|
Werbung
|
|||
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.05.16 | Novo Nordisk overweight | Barclays Capital | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.04.16 | Novo Nordisk Hold | Deutsche Bank AG | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk Sell | UBS AG | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.16 | Novo Nordisk Halten | Independent Research GmbH | |
| 08.02.16 | Novo Nordisk Sell | UBS AG | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk Neutral | UBS AG | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.16 | Novo Nordisk verkaufen | S&P Capital IQ | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
| 01.02.16 | Novo Nordisk Neutral | UBS AG | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 14.01.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 08.01.16 | Novo Nordisk overweight | Barclays Capital | |
| 07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
| 10.12.15 | Novo Nordisk Neutral | BNP PARIBAS | |
| 02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
| 01.12.15 | Novo Nordisk Halten | Independent Research GmbH | |
| 30.11.15 | Novo Nordisk Hold | Deutsche Bank AG | |
Werbung
Werbung